HomeLVTX • NASDAQ
add
LAVA Therapeutics NV
Previous close
$1.68
Day range
$1.68 - $1.74
Year range
$1.35 - $6.47
Market cap
44.69M USD
Avg Volume
69.44K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.36M | -42.56% |
Net income | -8.30M | 34.68% |
Net profit margin | — | — |
Earnings per share | -0.28 | 36.43% |
EBITDA | -9.24M | 31.00% |
Effective tax rate | -1.04% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 86.80M | -22.78% |
Total assets | 92.28M | -24.69% |
Total liabilities | 49.41M | -15.76% |
Total equity | 42.88M | — |
Shares outstanding | 26.30M | — |
Price to book | 1.03 | — |
Return on assets | -24.46% | — |
Return on capital | -44.22% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -8.30M | 34.68% |
Cash from operations | -8.38M | 35.83% |
Cash from investing | 339.00K | 51.34% |
Cash from financing | 5.00K | 103.18% |
Net change in cash | -8.10M | 37.67% |
Free cash flow | -5.12M | 43.73% |
About
CEO
Founded
2016
Website
Employees
37
